 |
|
Stent System Compliance |
|
Catheter Diam. (mm) |
2.5 |
2.75 |
3.0 |
3.5 |
4.0 |
Pressure
(MPa / Atm) |
Stent Diameters (mm) |
|
|
|
0.6 / 6 |
2.33 |
2.49 |
2.81 |
3.25 |
3.63 |
|
|
|
0.7 / 7 |
2.39 |
2.56 |
2.88 |
3.32 |
3.72 |
|
|
|
0.8 / 8 |
2.45 |
2.63 |
2.94 |
3.40 |
3.82 |
|
|
|
0.9 / 9 |
2.52 |
2.70 |
3.00 |
3.50 |
3.92 |
|
|
|
1.0 / 10 |
2.59 |
2.78 |
3.07 |
3.57 |
4.00 |
|
|
|
1.1 / 11 |
2.63 |
2.83 |
3.11 |
3.62 |
4.10 |
|
|
|
1.2 / 12 |
2.68 |
2.88 |
3.15 |
3.67 |
4.17 |
|
|
|
1.3 / 13 |
2.72 |
2.93 |
3.19 |
3.71 |
4.22 |
|
|
|
1.4 / 14 |
2.76 |
2.97 |
3.22 |
3.76 |
4.27 |
|
|
|
1.5 / 15 |
2.79 |
3.01 |
3.25 |
3.79 |
4.35 |
|
|
|
1.6 / 16 |
2.82 |
3.05 |
3.30 |
3.80 |
4.43 |
|
|
|
1.7 / 17 |
2.86 |
3.10 |
3.32 |
3.86 |
4.46 |
|
|
|
1.8 / 18 |
2.89 |
3.14 |
3.35 |
3.90 |
4.50 |
|
|
|
1.9 / 19 |
2.92 |
3.18 |
3.39 |
3.93 |
4.54 |
|
|
|
2.0 / 20 |
2.95 |
3.21 |
3.42 |
3.97 |
4.57 |
|
|
Do not exceed the Rated Burst Pressure, which is indicated in red.
Burst pressure (average) < 3.0mm: 26Atm
Burst pressure (average) >= 3.0mm: 25Atm
|
|
|
Product Specifications |
|
Catheter Length |
135cm |
|
Coaxial Lumen Length |
25cm |
|
Maximum guide wire diameter |
0.36mm (0.014") |
|
Stent foreshortening at nominal pressure |
< 2% |
|
Burst pressure |
25Atm |
|
Recommended Guide Wire |
0.014" (0.36mm) Max |
|
ChromoFlex Sizes and Order Codes |
| |
Stent Diameter (mm) |
Stent length |
2.5 |
2.75 |
3.0 |
3.5 |
4.0 |
|
|
11 |
CB1-2511 |
CB1-27511 |
CB1-3011 |
CB1-3511 |
CB1-4011 |
|
|
14 |
CB1-2514 |
CB1-27514 |
CB1-3014 |
CB1-3514 |
CB1-4014 |
|
|
17 |
CB1-2517 |
CB1-27517 |
CB1-3017 |
CB1-3517 |
CB1-4017 |
|
|
20 |
CB1-2520 |
CB1-27520 |
CB1-3020 |
CB1-3520 |
CB1-4020 |
|
|
24 |
CB1-2524 |
CB1-27524 |
CB1-3024 |
CB1-3524 |
CB1-4024 |
|
|
28 |
CB1-2528 |
CB1-27528 |
CB1-3028 |
CB1-3528 |
CB1-4028 |
|
|
|
Indications for Use
|
- For the treatment of stenotic lesions in native coronary arteries and aorto-coronary bypass grafts.
- For the treatment of restenosis or arterial dissection after PTCA.
|
|
Contra-indications |
- Patients who do not qualify for bypass surgery and/or PTCA.
- Patients who do not qualify for treatment with the necessary medication, like anticoagulant or anti-platelet therapy or others.
- Imminent thrombus formation and alteration of flow after myocardial infarction.
- Evidence of existing thrombus.
- Severe allergic reactions to the stent material or to the contrast medium.
- Treatment of an unprotected left main coronary artery lesion, of very proximal lesions, or of significant vessel tortuosity which prohibits guide wire access and sufficient guiding catheter support.
- Target lesions involving a major side branch.
- Target lesions distal to previously implanted stents.
- Patients in whom sufficient pre-dilatation of the lesion is not possible.
- Spasm of the arteries without evidence of stenoses or previously diagnosed severe coronary-arterial or arterial spasms.
|
Please also consider the latest medical research findings.
 |
